Published in J Stud Alcohol on January 01, 1996
Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Subst Abus (2009) 2.83
Participation in treatment and Alcoholics Anonymous: a 16-year follow-up of initially untreated individuals. J Clin Psychol (2006) 1.97
Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs (2009) 1.94
Mechanisms of behavior change in alcoholics anonymous: does Alcoholics Anonymous lead to better alcohol use outcomes by reducing depression symptoms? Addiction (2010) 1.86
Recovery capital as prospective predictor of sustained recovery, life satisfaction, and stress among former poly-substance users. Subst Use Misuse (2008) 1.73
Alcoholics anonymous effectiveness: faith meets science. J Addict Dis (2009) 1.63
Efficacy of peer support interventions for depression: a meta-analysis. Gen Hosp Psychiatry (2010) 1.63
An examination of main and interactive effects of substance abuse recovery housing on multiple indicators of adjustment. Addiction (2007) 1.60
Social recovery model: an 8-year investigation of adolescent 12-step group involvement following inpatient treatment. Alcohol Clin Exp Res (2008) 1.57
The Role of Social Supports, Spirituality, Religiousness, Life Meaning and Affiliation with 12-Step Fellowships in Quality of Life Satisfaction Among Individuals in Recovery from Alcohol and Drug Problems. Alcohol Treat Q (2006) 1.56
Helping other alcoholics in alcoholics anonymous and drinking outcomes: findings from project MATCH. J Stud Alcohol (2004) 1.54
Do adolescents affiliate with 12-step groups? A multivariate process model of effects. J Stud Alcohol (2002) 1.44
Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change. Psychol Addict Behav (2006) 1.41
Gender, acculturation, and other barriers to alcohol treatment utilization among Latinos in three National Alcohol Surveys. J Subst Abuse Treat (2008) 1.41
Facilitating involvement in Alcoholics Anonymous during out-patient treatment: a randomized clinical trial. Addiction (2009) 1.37
Social network variables in alcoholics anonymous: a literature review. Clin Psychol Rev (2007) 1.36
One small step for manuals: Computer-assisted training in twelve-step facilitation. J Stud Alcohol (2006) 1.29
The road to recovery: where are we going and how do we get there? Empirically driven conclusions and future directions for service development and research. Subst Use Misuse (2008) 1.28
Is it beneficial to have an alcoholics anonymous sponsor? Psychol Addict Behav (2010) 1.24
Mediators of telephone-based continuing care for alcohol and cocaine dependence. J Consult Clin Psychol (2007) 1.19
Organization and financing of alcohol and substance abuse programs for American Indians and Alaska Natives. Am J Public Health (2006) 1.16
Modeling the cost-effectiveness of health care systems for alcohol use disorders: how implementation of eHealth interventions improves cost-effectiveness. J Med Internet Res (2011) 1.13
Gender, treatment and self-help in remission from alcohol use disorders. Clin Med Res (2006) 1.11
Predictors of initial AA-related helping: findings from project MATCH. J Stud Alcohol Drugs (2009) 1.07
An Exploratory Investigation of the Association between Clinicians' Attitudes toward Twelve-step Groups and Referral Rates. Alcohol Treat Q (2005) 1.07
A novel application of propensity score matching to estimate Alcoholics Anonymous' effect on drinking outcomes. Drug Alcohol Depend (2012) 1.03
Emerging adults' treatment outcomes in relation to 12-step mutual-help attendance and active involvement. Drug Alcohol Depend (2012) 1.03
Impact of helping behaviors on the course of substance-use disorders in individuals with body dysmorphic disorder. J Stud Alcohol Drugs (2007) 1.02
Facilitating comprehensive assessment of 12-step experiences: A Multidimensional Measure of Mutual-Help Activity. Alcohol Treat Q (2011) 1.01
An exploration of the effect of on-site 12-step meetings on post-treatment outcomes among polysubstance-dependent outpatient clients. Eval Rev (2007) 0.99
Services received and treatment outcomes in day-hospital and residential programs. J Subst Abuse Treat (2008) 0.97
Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial. Drug Alcohol Depend (2012) 0.94
What do adolescents exposed to Alcoholics Anonymous think about 12-step groups? Subst Abus (2008) 0.93
Do 12-step meeting attendance trajectories over 9 years predict abstinence? J Subst Abuse Treat (2011) 0.92
The 10-year course of Alcoholics Anonymous participation and long-term outcomes: a follow-up study of outpatient subjects in Project MATCH. Subst Abus (2013) 0.92
Twelve-step program attendance and polysubstance use: interplay of alcohol and illicit drug use. J Stud Alcohol Drugs (2011) 0.90
Does sponsorship improve outcomes above Alcoholics Anonymous attendance? A latent class growth curve analysis. Addiction (2012) 0.89
Factors in sustained recovery from cocaine dependence. J Subst Abuse Treat (2013) 0.89
Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression. Addiction (2012) 0.88
Alcoholics Anonymous attendance, decreases in impulsivity and drinking and psychosocial outcomes over 16 years: moderated-mediation from a developmental perspective. Addiction (2011) 0.87
Does Alcoholics Anonymous work differently for men and women? A moderated multiple-mediation analysis in a large clinical sample. Drug Alcohol Depend (2012) 0.87
Estimating the efficacy of Alcoholics Anonymous without self-selection bias: an instrumental variables re-analysis of randomized clinical trials. Alcohol Clin Exp Res (2014) 0.86
Spirituality as a change mechanism in 12-step programs: a replication, extension, and refinement. Subst Use Misuse (2013) 0.86
Religiosity and participation in mutual-aid support groups for addiction. J Subst Abuse Treat (2007) 0.86
Convicted driving-while-impaired offenders' views on effectiveness of sanctions and treatment. Qual Health Res (2011) 0.86
Breaking the bond between stimulant use and risky sex: a qualitative study. Subst Abus (2010) 0.86
Oxford House and Alcoholics Anonymous: The Impact of Two Mutual-help Models on Abstinence. J Groups Addict Recover (2009) 0.86
How safe are adolescents at Alcoholics Anonymous and Narcotics Anonymous meetings? A prospective investigation with outpatient youth. J Subst Abuse Treat (2011) 0.85
The role of mutual-help groups in extending the framework of treatment. Alcohol Res Health (2011) 0.85
Attachment avoidance and anxiety as predictors of 12-step group engagement. J Stud Alcohol Drugs (2011) 0.85
Impressions of Alcoholics Anonymous (AA) Group Cohesion: A Case for a Nonspecific Factor Predicting Later AA Attendance. Alcohol Treat Q (2012) 0.84
The courage to change: patient perceptions of 12-Step fellowships. BMC Health Serv Res (2011) 0.84
Evaluating Alcoholics Anonymous's effect on drinking in Project MATCH using cross-lagged regression panel analysis. J Stud Alcohol Drugs (2013) 0.83
Development and validation of the Alcoholics Anonymous Intention Measure (AAIM). Drug Alcohol Depend (2009) 0.83
Treatment, alcoholics anonymous, and 16-year changes in impulsivity and legal problems among men and women with alcohol use disorders. J Stud Alcohol Drugs (2009) 0.83
A moderating role for gender in racial/ethnic disparities in alcohol services utilization: results from the 2000 to 2010 national alcohol surveys. Alcohol Clin Exp Res (2014) 0.83
Factors associated with attendance in 12-step groups (Alcoholics Anonymous/Narcotics Anonymous) among adults with alcohol problems living with HIV/AIDS. Drug Alcohol Depend (2010) 0.83
Alcohol and drug treatment involvement, 12-step attendance and abstinence: 9-year cross-lagged analysis of adults in an integrated health plan. J Subst Abuse Treat (2013) 0.82
Do women differ from men on Alcoholics Anonymous participation and abstinence? A multi-wave analysis of treatment seekers. Alcohol Clin Exp Res (2011) 0.82
Gender differences in mutual-help attendance one year after treatment: Swedish and U.S. samples. J Stud Alcohol Drugs (2010) 0.82
The importance of age composition of 12-step meetings as a moderating factor in the relation between young adults' 12-step participation and abstinence. Drug Alcohol Depend (2013) 0.81
Alcoholics Anonymous and hazardously drinking women returning to the community after incarceration: predictors of attendance and outcome. Alcohol Clin Exp Res (2010) 0.81
Alcoholics Anonymous and reduced impulsivity: a novel mechanism of change. Subst Abus (2013) 0.80
Participation in a novel treatment component during residential substance use treatment is associated with improved outcome: a pilot study. Addict Sci Clin Pract (2014) 0.80
12-step facilitation for the dually diagnosed: a randomized clinical trial. J Subst Abuse Treat (2013) 0.78
Spiritual awakening predicts improved drinking outcomes in a Polish treatment sample. J Addict Nurs (2013) 0.77
The Twelve Promises of Alcoholics Anonymous: psychometric measure validation and mediational testing as a 12-step specific mechanism of behavior change. Drug Alcohol Depend (2013) 0.77
Developing and Testing Twelve-Step Facilitation for Adolescents with Substance Use Disorder: Manual Development and Preliminary Outcomes. Subst Abuse (2016) 0.76
12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model. Subst Abus (2013) 0.76
The Relationship between Substance Abuse Performance Measures and Mutual Help Group Participation after Treatment. Alcohol Treat Q (2012) 0.75
Comparison of 12-step groups to mutual help alternatives for AUD in a large, national study: Differences in membership characteristics and group participation, cohesion, and satisfaction. J Subst Abuse Treat (2016) 0.75
Validation of the Full and Short-Form Self-Help Involvement Scale Against the Rasch Measurement Model. Eval Rev (2015) 0.75
Remission from alcohol and other drug problem use in public and private treatment samples over seven years. Drug Alcohol Depend (2011) 0.75
Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: a naturalistic, open-label study. Curr Clin Pharmacol (2014) 0.75
Is Alcoholics Anonymous religious, spiritual, neither? Findings from 25 years of mechanisms of behavior change research. Addiction (2016) 0.75
Brief interventions for alcohol problems: a review. Addiction (1993) 8.64
The reliability of Form 90: an instrument for assessing alcohol treatment outcome. J Stud Alcohol (1997) 4.39
Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J Clin Oncol (2001) 4.09
Concentrations of parabens in human breast tumours. J Appl Toxicol (2004) 3.98
Estimating blood alcohol concentration: two computer programs and their applications in therapy and research. Addict Behav (1979) 3.73
Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet (1999) 2.91
Effects of normative feedback on consumption among heavy drinking college students. J Drug Educ (1995) 2.38
The cost effectiveness of treatment for alcoholism: a first approximation. J Stud Alcohol (1991) 2.13
Motivation for treatment: a review with special emphasis on alcoholism. Psychol Bull (1985) 2.03
Significance of aromatase activity in human breast cancer. Cancer Res (1982) 1.97
Does Alcoholics Anonymous involvement predict treatment outcome? J Subst Abuse Treat (1996) 1.81
Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. Br J Cancer (1995) 1.81
A longitudinal model of intake symptomatology, AA participation and outcome: retrospective study of the project MATCH outpatient and aftercare samples. J Stud Alcohol (2001) 1.74
Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol (1999) 1.60
Focused versus broad-spectrum behavior therapy for problem drinkers. J Consult Clin Psychol (1980) 1.56
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature (1985) 1.53
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer (1996) 1.51
Relative effectiveness of bibliotherapy, individual and group self-control training in the treatment of problem drinkers. Addict Behav (1980) 1.43
Where to publish? Some considerations among English-language addiction journals. Addiction (1997) 1.42
Nipple aspirate fluid in relation to breast cancer. Breast (1999) 1.41
A human tumour model. Lancet (1986) 1.39
Steroid metabolism by human breast and rat mammary carcinomata. Steroids (1974) 1.36
p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer (1990) 1.24
Atheists, agnostics and Alcoholics Anonymous. J Stud Alcohol (2002) 1.21
Inpatient alcoholism treatment. Who benefits? Am Psychol (1986) 1.21
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer. J Steroid Biochem Mol Biol (2005) 1.18
Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br Med J (Clin Res Ed) (1988) 1.16
Oestradiol synthesis by a human breast carcinoma. Lancet (1974) 1.15
The community reinforcement approach to the treatment of substance use disorders. Am J Addict (2001) 1.15
Depression and learned helplessness in man. J Abnorm Psychol (1975) 1.13
Expression of transforming growth factor beta mRNA isoforms in human breast cancer. Br J Cancer (1994) 1.13
Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies. Br J Cancer (2002) 1.13
Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J Steroid Biochem Mol Biol (2001) 1.13
Community reinforcement and family training (CRAFT): engaging unmotivated drug users in treatment. J Subst Abuse (1998) 1.11
Expression of the heat shock protein HSP27 in human ovarian cancer. Clin Cancer Res (1995) 1.10
The relationship of cyst type to risk factors for breast cancer and the subsequent development of breast cancer in patients with breast cystic disease. Eur J Cancer Clin Oncol (1985) 1.10
Differences among AA groups: implications for research. J Stud Alcohol (1993) 1.09
Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours. Br J Cancer (2000) 1.08
Behavioral treatment of problem drinkers: a comparative outcome study of three controlled drinking therapies. J Consult Clin Psychol (1978) 1.08
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg (1987) 1.07
Risk factors for breast cancer. BMJ (1995) 1.07
Effectiveness of a self-control manual for problem drinkers with and without therapist contact. Int J Addict (1981) 1.06
Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. Br J Cancer (1994) 1.06
Thrombospondin in malignant and non-malignant breast tissue. Eur J Cancer Clin Oncol (1989) 1.05
Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. Cancer Res (1987) 1.05
Drinking and thinking: how does personal drinking affect judgments of prevalence and risk? J Stud Alcohol (1994) 1.04
Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. Eur J Cancer (2000) 1.04
Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity. Br J Cancer (1986) 1.03
Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissue. Eur J Cancer (1996) 1.03
In vitro effects of oestrogen on 5alpha reduction of testosterone in hormone-dependent rat mammary carcinomata. Br J Cancer (1976) 1.01
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol (1994) 1.01
Peer-managed self-control program for prevention of alcohol abuse in American Indian high school students: a pilot evaluation study. Int J Addict (1985) 1.00
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen. Clin Cancer Res (1998) 0.99
Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity. Eur J Cancer Clin Oncol (1985) 0.99
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer (1990) 0.99
Tamoxifen induced apoptosis in ZR-75 breast cancer xenografts antedates tumour regression. Breast Cancer Res Treat (1997) 0.98
Metabolism of androgens by human breast tissue. Lancet (1973) 0.98
Psychological deficit in depression. Psychol Bull (1975) 0.98
c-erbB growth-factor-receptor proteins in ovarian tumours. Int J Cancer (1995) 0.97
Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment. Endocr Relat Cancer (2005) 0.97
c-erbB-3 protein expression in ovarian tumours. Br J Cancer (1995) 0.97
Intercessory prayer in the treatment of alcohol abuse and dependence: a pilot investigation. Altern Ther Health Med (1997) 0.97
The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study. Clin Cancer Res (2000) 0.97
Transforming growth factor-beta isoform expression in human ovarian tumours. Eur J Cancer (1997) 0.97
Growth inhibition of oestrogen receptor-positive human ovarian carcinoma by anti-oestrogens in vitro and in a xenograft model. Eur J Cancer (1994) 0.97
The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res Treat (1991) 0.97
Steroid metabolism and oestrogen receptors in human breast carcinomas. Eur J Cancer Clin Oncol (1981) 0.96
Comparison of three alcohol consumption measures: a concurrent validity study. J Stud Alcohol (1995) 0.96
Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. Br J Cancer (2009) 0.96
Cyclic AMP binding proteins in human breast cancer. Br J Cancer (1985) 0.95
Expression of glutathione S-transferase B1, B2, Mu and Pi in breast cancers and their relationship to oestrogen receptor status. Br J Cancer (1989) 0.95
Oestradiol synthesis from C19 steroids by human breast cancers. Br J Cancer (1976) 0.95
Cyclic adenosine 3',5'-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features. Clin Cancer Res (1996) 0.95
Comparison of outcomes for clients in randomized versus open trials of treatment for alcohol use disorders. J Stud Alcohol (2000) 0.95
Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res Treat (2001) 0.94
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report. J Steroid Biochem Mol Biol (2003) 0.93
Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol (1994) 0.93
The pharmacology of letrozole. J Steroid Biochem Mol Biol (2003) 0.93
Development of interagency coordination in a program of comprehensive medical care. Am J Public Health Nations Health (1966) 0.93
Estrogen regulation of transforming growth factor-alpha in ovarian cancer. J Steroid Biochem Mol Biol (1998) 0.93
Effect of Matrigel on the tumorigenicity of human breast and ovarian carcinoma cell lines. Int J Cancer (1996) 0.92
Are reconstructed self-reports of drinking reliable? Addiction (1997) 0.92
Alcohol, drug use and consequences among Hispanics seeking treatment for alcohol-related problems. J Stud Alcohol (1996) 0.92
Oestrogen receptors in transplantable ovary-independent, mammary tumours of the rat. Eur J Cancer (1978) 0.92
Amount of therapist contact and outcome in a multidimensional depression treatment program. Acta Psychiatr Scand (1983) 0.91
MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue. BJU Int (2003) 0.91
AA group dynamics and 12-step activity. J Stud Alcohol (1995) 0.90
Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines. Eur J Cancer (1992) 0.90
Morphological and biological observations relating to the development and progression of breast cancer. Cancer Treat Res (1994) 0.90
Treatment of nightmares via relaxation and desensitization: a controlled evaluation. J Consult Clin Psychol (1983) 0.90
Special populations in Alcoholics Anonymous. Alcohol Health Res World (1998) 0.90
Variations associated with the DNA analysis of multiple fine needle aspirates obtained from breast cancer patients. Br J Cancer (1989) 0.89
Looking forward and back to relapse: implications for research and practice. Addiction (1996) 0.89
Alcoholism scales and objective assessment methods: a review. Psychol Bull (1976) 0.89
Hormonal factors and risk of breast cancer. Lancet (1993) 0.89
Oestrogen receptor activity and endocrine status in DMBA-induced rat mammary tumours. Eur J Cancer (1977) 0.89
Hyperprolactinemia and steroid metabolism by rat mammary adenocarcinomas. Cancer Res (1976) 0.88
Lipolytic activity in the pancreas. Biochem J (1969) 0.88
Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer. Br J Cancer (1987) 0.88
Cellularity and the quantitation of estrogen receptors. Breast Cancer Res Treat (1982) 0.88